Schieda Nicola, Krishna Satheesh, McInnes Matthew D F, Moosavi Bardia, Alrashed Abdulmohsen, Moreland Robert, Siegelman Evan S
1 Department of Medical Imaging, The Ottawa Hospital, The University of Ottawa, 1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada.
2 Department of Radiology and Medical Imaging, King Saud University Medical City, King Khaled University Hospital, Riyadh, Kingdom of Saudi Arabia.
AJR Am J Roentgenol. 2017 Sep;209(3):W152-W159. doi: 10.2214/AJR.16.17649. Epub 2017 Jul 25.
The purpose of this study is to compare MRI features of clear cell renal cell carcinoma (RCC) adrenal metastases and adenomas.
Fifteen clear cell RCC adrenal metastases imaged with MRI were compared to 29 consecutive adenomas between 2006 and 2015. Two blinded radiologists assessed homogeneity (homogeneous vs heterogeneous), signal intensity (SI) decrease on chemical-shift MRI, and T2-weighted SI (isointense, mildly hyperintense, or markedly hyperintense) relative to muscle. A third blinded radiologist measured the chemical-shift SI index, adrenal-to-spleen SI ratio, T2-weighted SI ratio, AUC for contrast-enhanced MRI, and histogram analysis. Analyses were performed using chi-square, linear regression, ROC, and logistic regression modeling.
Clear cell RCC metastases were larger than adenomas (mean [± SD], 5.0 ± 4.2 cm [range, 1.1-15 cm] vs 2.0 ± 0.7 cm [range, 1.2-3.7 cm]; p < 0.0001). Subjectively, 33.3% (5/15) of metastases and 68.9% (20/29) of adenomas showed an SI decrease on chemical-shift MRI (p = 0.0421; κ = 0.76). Chemical-shift SI index (mean, 9.2% ± 20.6%; range, -30.0% to 57.9%) and adrenal-to-spleen SI ratio (0.94 ± 0.23 [range, 0.44-1.33]) for metastases differed significantly from those for adenomas (47.3% ± 27.8% [range, -9.4% to 86%] and 0.52 ± 0.28 [range, 0.13-1.11], respectively) (p < 0.0001). Twenty percent (3/15) of metastases had chemical-shift SI index in the adenoma range (> 16.5%). Metastases had higher T2-weighted SI than did adenomas, both quantitatively (5.1 ± 3.0 [range, 1.5-10.6] vs 1.8 ± 0.8 [range, 0.5-3.8]; p < 0.0001) and subjectively (p < 0.0001; κ = 0.89). Metastases had higher entropy than did adenomas (6.76 ± 0.61 vs 6.1 ± 0.74; p = 0.0051) and were subjectively more heterogeneous (p < 0.0001; κ = 0.86). The contrast-enhanced MRI AUC, skewness, and kurtosis did not differ between groups (p > 0.05). The ROC AUCs were 0.91 (95% CI, 0.79-1.0) for T2-weighted SI ratio and 0.85 (95% CI, 0.68-1.0) for entropy. The logistic regression model of T2-weighted SI ratio plus entropy improved accuracy (ROC AUC, 0.97; 95% CI, 0.93-1.0]) compared with either feature alone (p = 0.0215).
Increased T2-weighted SI and heterogeneity are features that can differentiate clear cell RCC adrenal metastases from adenomas using quantitative and subjective analysis.
本研究旨在比较透明细胞肾细胞癌(RCC)肾上腺转移瘤与腺瘤的MRI特征。
将2006年至2015年间15例经MRI成像的透明细胞RCC肾上腺转移瘤与29例连续的腺瘤进行比较。两名盲法放射科医生评估了均匀性(均匀与不均匀)、化学位移MRI上的信号强度(SI)降低情况以及相对于肌肉的T2加权SI(等信号、轻度高信号或明显高信号)。第三名盲法放射科医生测量了化学位移SI指数、肾上腺与脾脏SI比值、T2加权SI比值、对比增强MRI的AUC以及直方图分析。使用卡方检验、线性回归、ROC分析和逻辑回归模型进行分析。
透明细胞RCC转移瘤比腺瘤大(平均[±标准差],5.0±4.2 cm[范围,1.1 - 15 cm]对2.0±0.7 cm[范围,1.2 - 3.7 cm];p<0.0001)。主观上,33.3%(5/15)的转移瘤和68.9%(20/29)的腺瘤在化学位移MRI上显示SI降低(p = 0.0421;κ = 0.76)。转移瘤的化学位移SI指数(平均,9.2%±20.6%;范围,-30.0%至57.9%)和肾上腺与脾脏SI比值(0.94±0.23[范围,0.44 - 1.33])与腺瘤(分别为47.3%±27.8%[范围, -9.4%至86%]和0.52±0.28[范围, 0.13 - 1.11])有显著差异(p<0.0001)。20%(3/15)的转移瘤化学位移SI指数在腺瘤范围内(>16.5%)。转移瘤的T2加权SI高于腺瘤,在定量上(5.1±3.0[范围,1.5 - 10.6]对1.8±0.8[范围,0.5 - 3.8];p<0.0001)和主观上(p<0.0001;κ = 0.89)均如此。转移瘤的熵高于腺瘤(6.76±0.61对6.1±0.74;p = 0.0051),且主观上更不均匀(p<0.0001;κ = 0.86)。对比增强MRI的AUC、偏度和峰度在两组之间无差异(p>0.05)。T2加权SI比值的ROC AUC为0.91(95%CI,0.79 - 1.0),熵的ROC AUC为0.85(95%CI, 0.68 - 1.0)。与单独使用任何一个特征相比(p = 0.0215),T2加权SI比值加熵的逻辑回归模型提高了准确性(ROC AUC,0.97;95%CI,0.93 - 1.0)。
T2加权SI增加和不均匀性是通过定量和主观分析可将透明细胞RCC肾上腺转移瘤与腺瘤区分开来的特征。